UH Researchers Receive $1.2 Million Grant to Peer into Ribosomes
A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and New York-Presbyterian physician-scientists who performed the transplant and managed her care.
A Cornell-led collaboration aims to energize the development of more sustainable pharmaceutical products by employing electrochemistry to stitch together simple carbon molecules and form complex compounds, eliminating the need for precious metals or other catalysts to promote the chemical reaction.
UH Researcher Receives $2M Grant to Innovate Computer-aided Drug Discovery for Breast Cancer
Menopause marks the end of a woman’s fertility, but it can also bring about a slew of other — often baffling — changes, from weight gain to brain fog.
The building blocks of life-saving therapeutics could be developed in days instead of years thanks to new software that simulates evolution.
Rice immunotherapy treatment could begin human clinical trials this year
UCLA researchers presented today the first case of a U.S. woman living with HIV-1 that is in remission after she received a new combination of specialized stem cell transplants for treatment of acute myeloid leukemia (AML). The oral abstract was presented at CROI 2022, the Conference on Retroviruses and Opportunistic Infections.
Findings could have future implications for precision medicine, lead to individualized treatments.
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial infection that has become resistant to most of the antibiotics used to treat regular staph infections.
Korean scientists have designed a magnetically controlled wireless capsule that can efficiently and non-invasively deliver treatment drugs to patients who have gastrointestinal cancer.
Researchers at the University of Gothenburg in Sweden have achieved a deeper understanding of the chemical structure of intestinal mucus, a key part of the body’s innate immune system.
Researchers at the University of Missouri and the University of Minnesota have discovered how HIV evades one of the body’s best defenses – and their collaborative work could offer hope for future treatments that stop the spread of HIV in the body.Messenger RNA (mRNA) from HIV is known to utilize a host cell’s system in order to create its own viral proteins.
Tuberculosis is currently the deadliest infectious disease in the world, affecting nearly 2 billion people. It is caused by the organism Mycobacterium tuberculosis.
The full genome of nine different bacteriophages used in one of the first modern applications of this promising type of antibacterial agent in the United States was published last month. Also published were the genomes of three strains of the multidrug-resistant bacteria, Acinetobacter baumannii, that the phages targeted.
A molecule developed by researchers at the University of Helsinki can inactivate the coronavirus spike protein and offers effective short-term protection against the virus.
Research led by the University of Alabama in Huntsville (UAH) has for the first time identified the precise genetic operational structure of a key system in Escherichia coli (E. coli) bacteria, opening the door to possible new antibiotics to treat the infections it causes.
Researchers demonstrated an effective new tool for mapping genetic variants in sequencing data using ‘pangenomics’ instead of a single reference genome
A CRISPR-based gene editing technique called twin prime editing could be a new and safer approach to gene therapy.
The condition is more common — and problematic — than thought